Pfizer Leads Rx Rebound At End Of Quarter: Will FDA Appointment Fuel Rally?
Executive Summary
Pfizer's late September rally is an indication that pharmaceutical stocks are living up to their reputation as a secure investment during periods of economic uncertainty.